INmune Bio Inc
NASDAQ:INMB 11:42:47 AM EDT
Market Cap (Intraday) | 207.08M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $11.69 |
50-Day MA | $12.07 |
200-Day MA | $9.52 |
INmune Bio Inc Stock, NASDAQ:INMB
225 NE Mizner Boulevard, Suite 640, Boca Raton, Florida 33432
United States of America
Phone: +1.858.964.3720
Number of Employees: 10
Description
INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer�s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.